Status:
NOT_YET_RECRUITING
Predicting Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
Lead Sponsor:
Assiut University
Conditions:
Locally Advanced Breast Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Female breast cancer is the second leading cause of global cancer incidence in 2022 and the fourth leading cause of cancer mortality worldwide. Breast cancer (BC) remains the most prevalent cancer dia...
Detailed Description
Formalin fixed paraffin embedded tissue specimen of the baseline TCNB of locally advanced breast cancer will be obtained from pathology laboratory, Pathology Department, Assiut University. * Histolog...
Eligibility Criteria
Inclusion
- Patients above 18 years
- Pathologically proven breast carcinoma
- Locally advanced breast cancer
Exclusion
- Patients below 18 years.
- Patients with metastatic disease
- Patients with second primary cancer
- Patients ineligible for chemotherapy
Key Trial Info
Start Date :
August 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2027
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06499168
Start Date
August 1 2024
End Date
August 1 2027
Last Update
July 12 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.